Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
The FDA classified BPC-157 as a Category 2 bulk drug substance in 2023, meaning it cannot be compounded by commercial pharmaceutical companies and there is insufficient evidence regarding potential human harm
It also has anti-inflammatory properties, helping to calm redness, irritation, and sensitivity
Common formulations include 5mg, 10mg, 15mg, and 30mg vials
Common symptoms involve brain fog, issues with focus, memory lapses, depression, or mood fluctuations
If you move from a 10mg vial with 2ml of water to a 30mg vial with 3ml of water, the units per dose change completely
The occipital artery and the pterygopalatine artery (PPA) were permanently ligated
